Lexicon Pharmaceuticals, Inc.
USE OF SOTAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND MODERATE RENAL IMPAIRMENT
Last updated:
Abstract:
The invention relates to the use of sotagliflozin inpatients with type 2 diabetes mellitus and moderate renal impairment.
Status:
Application
Type:
Utility
Filling date:
24 Jul 2020
Issue date:
25 Aug 2022